Latest Content

Head and Neck Cancer: Self Exams, Vaccines, Treatment and More

May 12th 2021, 9:00pm

By Kristie L. Kahl

Video

In this edition of the Speaking Out video series, on behalf of the Head and Neck Cancer Alliance, CURE spoke with Dr. Michael Moore, from Indiana University School of Medicine about the basics of head and neck cancer.

Opioid Epidemic Negatively Influences Opioid Use for Pain Management in Advanced Cancer

May 12th 2021, 6:00pm

By Darlene Dobkowski, MA

Article

According to a survey of 26 patients with advanced cancer, many reported that the U.S. opioid epidemic impacted their opinions of opioid use for pain management and conversations with their clinician regarding prescriptions.

My Story: In Defense of Grief

May 12th 2021, 4:00pm

By Robin Zimmerman

Article

A man who lost his wife to melanoma explains how he channeled his grief into advocacy that led to a change in legislation.

Eating Mushrooms May Reduce Cancer Risk

May 12th 2021, 3:00pm

By Colleen Moretti

Article

Participants who ate 18 grams of mushrooms a day had a 45% lower risk of developing cancer compared to those who do not eat them.

Childhood Down Syndrome and Acute Myeloid Leukemia Association ‘Greater Than Previously Reported’

May 12th 2021, 1:00pm

By Ryan McDonald

Article

An analysis of more than 3.5 million children born between January 1996 and December 2016 demonstrated a stronger association between Down syndrome and acute myeloid leukemia risk than has been previously reported.

Trial to Investigate Experimental Drug’s Effect on Improving Survival in Refractory Myelofibrosis

May 11th 2021, 9:00pm

By Ryan McDonald

Article

The Geron Corporation announced that the first patient has been dosed with GRN163L — an experimental agent — in a phase 3 clinical trial to assess the drug’s overall survival benefit compared to best available therapy in patients with refractory myelofibrosis.

Early Study Results Show Novel Therapy Safe and Effective in Relapsed/Refractory Acute Myeloid Leukemia

May 11th 2021, 6:00pm

By Ryan McDonald

Article

Treatment with a novel therapy as a single agent, or in combination with Venclexta, demonstrated a manageable safety profile and antileukemic effects in patients with relapsed/refractory acute myeloid leukemia. The study authors, however, note that more research is needed.

My Nemesis the Gold-Capped Vial

May 11th 2021, 4:00pm

By Marissa Holzer

Article

A woman with metastatic breast cancer describes the overwhelming dread she feels every time she must wait to hear the results of a tumor marker test.

Patients with Hematologic Cancers Benefit from a Walking Program

May 11th 2021, 3:00pm

By Jessica Skarzynski

Article

Prior to the program, patients with hematologic cancers walked an average of 136 steps in a 24-hour period. One month after the program began, that total increased to an average of 1,018 steps per day.

Jakafi-Novel Therapy Combo Improves Symptom Burden in Patients with Myelofibrosis

May 11th 2021, 1:00pm

By Ryan McDonald

Article

Treatment with daily Jakafi and parsaclisib improved spleen volume reduction and symptom burden in patients with myelofibrosis who had previously failed to achieve significant response to single-agent Jakafi.

The Role of Tumor Infiltrating Lymphocyte (TIL) Therapy in NSCLC

May 11th 2021, 12:45pm

By CURE Media Group

Video

An expert in thoracic oncology, Adam J. Schoenfeld, MD, provides key insight into the use of cell therapy in non-small cell lung cancer after first-line treatment and highlights the potential for tumor-infiltrating lymphocyte (TIL) therapy depending on results from ongoing clinical trials.

Doctor’s Experience as a Cancer Caregiver Is Helping Educate Others

May 10th 2021, 9:00pm

By Darlene Dobkowski, MA

Article

A gynecologic oncologist who has spent her career helping patients during their cancer journeys goes a step further to educate women on how to advocate for themselves and possibly prevent cancer before it occurs.

Patients with Rare Cancers Offer Others Who May Be Facing a Similar Diagnosis Advice

May 10th 2021, 6:00pm

By Ryan McDonald

Article

On social media, CURE® recently asked its readers with rare cancers what advice they would offer to fellow patients with a similar diagnosis. Here’s what they shared.

A Pep Talk On COVID-19 Vaccinations From a Cancer Survivor

May 10th 2021, 4:00pm

By Felicia Mitchell

Article

Some experiences we have as cancer survivors may help inspire those reluctant to get or complete COVID-19 vaccinations to follow through. We are all role models for each other.

Neoadjuvant Libtayo Shows Promise for Patients With Hepatocellular Carcinoma

May 10th 2021, 3:00pm

By Colleen Moretti

Article

Twenty percent of patients with resectable hepatocellular carcinoma had a significant amount of cell death when receiving Libtayo before surgical intervention.